News

New genes found that regulate development of stem cells.

Three-year research programme in cooperation with two other European epigenetics companies funded.

Genomics’ proprietary statistical analysis tools and integrated multi-phenotype database will be used to inform Biogen’s drug research and development processes.

Variations in DNA at a specific location on the genome that protect African children from developing severe malaria, in some cases nearly halving a child’s chance of developing the life-threatening disease, have been identified in the largest genetic association study of malaria to date.

An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.

SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology based at Imperial College London, is running a new Lean Launchpad for budding entrepreneurs wanting to start synthetic biology businesses.

Collaboration for next-generation sequencing cancer diagnostics in China.

NIH human and mouse study may open an unexplored path for finding treatments.

A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.

Company wins contract to provide genome interpretation for 8,000 patients participating in the 100,000 Genomes Project.